1-7 of 7
Dai Chihara, MDPhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Studies in Hematologic Malignancy: 20-Year Experience from Cancer Therapy Evaluation Program (CTEP) at National Cancer Institute/National Institutes of Health

Dai Chihara, MDPhD, Erich P. Huang, PhD, Shanda R. Finnigan, MPH, RN, Lisa M. Cordes, PharmD, Nebojsa Skorupan, MD, Yoko Korenaga Fukuda, MD, Larry V. Rubinstein, PhD, Naoko Takebe, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 18.
https://doi.org/10.1182/blood-2020-140159
Published: 2020
Journal Articles

Body Mass Index and Survival of Patients with Lymphoma

Dai Chihara, MDPhD, Melissa C. Larson, MS, Dennis P. Robinson, Carrie A. Thompson, MD, Matthew J. Maurer, MS, Carla Casulo, MD, Brian K. Link, MD, Thomas M. Habermann, MD, Andrew L. Feldman, MD, Christopher Flowers, MDMS, James R. Cerhan, MD PhD, Lindsay M. Morton, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 2–3.
https://doi.org/10.1182/blood-2020-139402
Published: 2020
Journal Articles

Difference in Survival Outcome of Primary Central Nervous System Lymphoma By Histologic Types

Dai Chihara, MDPhD, Nathan H. Fowler, MD, Yasuhiro Oki, MD, Michelle A. Fanale, MD, Loretta Nastoupil, MD, Jason R. Westin, MD, Luis E. Fayad, Sattva S. Neelapu, MD, Chan Yoon Cheah, MBBS
Journal: Blood
Blood (2017) 130 (Supplement 1): 4137.
https://doi.org/10.1182/blood.V130.Suppl_1.4137.4137
Published: 2017
Journal Articles

The Role of Radiation Therapy and Risk of Developing Secondary Gastric Cancer in Patients Presenting with Early Stage Gastric Lymphoma

Dai Chihara, MDPhD, Bouthaina S. Dabaja, MD, Yasuhiro Oki, MD, Jason R. Westin, MD, Chan Yoon Cheah, MBBS, Chelsea C Pinnix, MD, Sattva S. Neelapu, MD, Michelle A. Fanale, MD, Nathan H. Fowler, MD, Loretta Nastoupil, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4138.
https://doi.org/10.1182/blood.V130.Suppl_1.4138.4138
Published: 2017
Journal Articles

Myelofibrosis (MF) Leukemic Transformation (LT) in the Era of Ruxolitinib and Genomics: Characteristics and Outcomes

Lorenzo Falchi, MD, Dai Chihara, MDPhD, Prithviraj Bose, MD, Zeev Estrov, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MBBS, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4185.
https://doi.org/10.1182/blood.V130.Suppl_1.4185.4185
Published: 2017
Journal Articles

Stage I Lymphoma: Difference in Survival Outcome By Site of Involvement

Dai Chihara, MDPhD, Yasuhiro Oki, MD, Michelle A. Fanale, MD, Jason R. Westin, MD, Loretta Nastoupil, MD, Sattva S. Neelapu, MD, Luis E. Fayad, Nathan H. Fowler, MD, Chan Yoon Cheah, MBBS
Journal: Blood
Blood (2017) 130 (Supplement 1): 1569.
https://doi.org/10.1182/blood.V130.Suppl_1.1569.1569
Published: 2017
Journal Articles

Survival Outcome of Secondary Solid Cancer in Patients with Chronic Myeloid Leukemia

Hamzah Munir Alqam, MD, Hagop M. Kantarjian, MD, Dai Chihara, MDPhD, Koji Sasaki, MD, Elias J. Jabbour, MD, Jorge E. Cortes, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1623.
https://doi.org/10.1182/blood.V130.Suppl_1.1623.1623
Published: 2017